ST

Solvonis Therapeutics

Organization

Heard in 2 episodes across 1 show since Aug 2026

A UK-listed biopharmaceutical company developing medicines in areas including mental health and central nervous system disorders, with esketamine-related programmes among its priorities.

Episodes

2
across 1 show

First heard

Aug 2026

Expert statements

5
5 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20260
Oct 20261

What experts have said about Solvonis Therapeutics

5 statements · 5 positive

  1. David John NuttPositiveOct 4, 2026· The Sunday Roast

    Solvonis researchers discovered a molecule combining targeted antidepressant pharmacologies.

    “we've discovered in our research a molecule that fits that particular criteria.”

    Listen at 1:02:04

    Open the episode · S12 Ep6: Sunday Roast - Mantle Resilience Plc,Xtract Resources,Bezant Resources,Solvonis Therapeutics plc, African Pioneer, Kendrick Resources, Active Energy Group PLC, Critical Mineral Resources & Galileo Resources #MNTL #XTR #BZT #SVNS #AFP #KEN #AEG #CMRS #GLR
  2. David John NuttPositiveOct 4, 2026· The Sunday Roast

    Solvonis’s molecule is designed to improve enjoyment while reducing SSRI-related adverse effects.

    “It'll promote mood and what we call hedonic tone and enjoyment, but also offset any of the unwanted negative effects of the SSRIs.”

    Listen at 1:04:09

    Open the episode · S12 Ep6: Sunday Roast - Mantle Resilience Plc,Xtract Resources,Bezant Resources,Solvonis Therapeutics plc, African Pioneer, Kendrick Resources, Active Energy Group PLC, Critical Mineral Resources & Galileo Resources #MNTL #XTR #BZT #SVNS #AFP #KEN #AEG #CMRS #GLR
  3. Anthony TennysonPositiveAug 26, 2026· The Sunday Roast

    Tennyson believes Solvonis has a very good business and plan.

    “We are, we have a, what I believe to be a very good business. with a very good plan.”

    Listen at 14:05

    Open the episode · S11 Ep100: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring Solvonis Therapeutics, newest first

Solvonis Therapeutics · PodLume